About
Novartis AG is a Swiss multinational pharmaceutical corporation founded in 1996 through the merger of Ciba-Geigy and Sandoz, headquartered in Basel, Switzerland. The company explores quantum computing applications for drug discovery, including molecular simulation, protein folding, drug-target interaction modeling, and pharmaceutical development. Novartis collaborates with quantum computing providers and quantum software companies to develop quantum algorithms for computational drug discovery, and it investigates quantum machine learning for analyzing pharmaceutical data and quantum simulation for understanding complex biological molecules. Through this work, the company advances practical quantum applications for healthcare and aims to accelerate pharmaceutical development using quantum technology and quantum-enhanced computational chemistry.
Quantum Specifications
| Quantum Focus | software |
Backed By
Frequently Asked Questions
Related News
Novartis Yo-Yoes As Generics Take A Bite Out Of Its First-Quarter Sales
Novartis CEO warns reality of Trump's drug pricing policy will set in over 'the next 18 months'
Novartis shells out $2 billion for immunology biotech Excellergy, in second multi-billion dollar deal in a week
Novartis Promises Growth Despite 'Historic' Patent Cliffs - I Broadly Agree
Novartis to Sell $11 Billion Bonds to Fund Avidity Deal
